Trademark: 90350942
Word
THYQUIDITY (LEVOTHYROXINE SODIUM) ORAL SOLUTION 100 MCG/5ML
Status Date
Monday, May 8, 2023
Filing Date
Tuesday, December 1, 2020
Published for Opposition
Tuesday, February 8, 2022
Abandoned Date
Monday, May 8, 2023
5 pharmaceutical preparations for the treatment of hypothyroidism, thyroid hormone deficiency, myxedema and thyroid tumors
The mark consists of a stylized infinity symbol followed by the text THYQUIDITY above the text "(LEVOTHYROXINE SODIUM)" above the text "100MGC/5ML".
THYQUIDITY (LEVOTHYROXINE SODIUM) ORAL SOLUTION ONE HUNDRED MICRO GRAMS FIVE MILLILITERS; THYQUDITY (LEVOTHYROXINE SODIUM) ORAL SOLUTION ONE ZERO ZERO MICROGRAM/FIVE MILLILITERS
"(LEVOTHYROXINE SODIUM) ORAL SOLUTION 100 MCG/5ML"
May 8, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 8, 2023
Abandonment - No Use Statement Filed
Oct 19, 2022
Automatic Update Of Assignment Of Ownership
Oct 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 4, 2022
Sou Extension 1 Granted
Oct 4, 2022
Sou Extension 1 Filed
Oct 4, 2022
Teas Extension Received
Aug 3, 2022
Assignment Of Ownership Not Updated Automatically
Apr 5, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 8, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 8, 2022
Published For Opposition
Jan 19, 2022
Notification Of Notice Of Publication E-Mailed
Jan 6, 2022
Approved For Pub - Principal Register
Jan 6, 2022
Examiner's Amendment Entered
Jan 6, 2022
Notification Of Examiners Amendment E-Mailed
Jan 6, 2022
Examiners Amendment E-Mailed
Jan 6, 2022
Examiners Amendment -Written
Nov 16, 2021
Teas/Email Correspondence Entered
Nov 16, 2021
Correspondence Received In Law Office
Nov 16, 2021
Teas Response To Office Action Received
May 19, 2021
Notification Of Non-Final Action E-Mailed
May 19, 2021
Non-Final Action E-Mailed
May 19, 2021
Non-Final Action Written
May 18, 2021
Assigned To Examiner
Feb 6, 2021
Notice Of Design Search Code E-Mailed
Feb 5, 2021
New Application Office Supplied Data Entered
Dec 4, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24